Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 4961 - 4968 of 12008 results
Open Payments Program Expansion
August 12, 2019| Blog| Viewpoint
August Cybersecurity Update: Congress Finishes Up NDAA and Continues Work on Cybersecurity Bills
August 12, 2019| Blog| Viewpoint
New York Approves Major Offshore Wind Energy Deal
August 12, 2019| Blog| Viewpoint
PTAB Confirms (Again) that the AIA’s “Enhanced Estoppel” Provision Applies to Concurrent IPR Proceedings
August 12, 2019| Blog| Viewpoint
Continental AG Announces Shifting Focus to Electric Future and Clean Air
August 9, 2019| News
Give and Take: IPR of Pre-AIA Patent is NOT an Unconstitutional Taking
August 9, 2019| Blog| Viewpoint
Effect of Prosecution History Estoppel on Infringement Claim under Doctrine of Equivalents
August 9, 2019| Blog| Viewpoint
In Policy Reversal, HHS and FDA Propose Plan to Import Foreign Drugs
August 8, 2019| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|